|
|
|
Insider
Information: |
Lilly Eli & Co |
Relationship: |
10% Owner |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
17,228,056 |
|
Indirect Shares
|
2,568,543 |
|
|
Direct
Value |
$1,634,192,970 |
|
|
Indirect Value
|
$1,542,924 |
|
|
Total
Shares |
19,796,599 |
|
|
Total
Value |
$1,635,735,894 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Icagen Inc |
ICGN |
10% Owner |
2005-02-08 |
300,340 |
2005-02-08 |
0 |
Premium* |
|
Ionis Pharmaceuticals Inc |
IONS |
10% Owner |
2005-08-05 |
2,500,000 |
|
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
10% Owner |
2011-07-06 |
5,251,394 |
|
0 |
Premium* |
|
Zosano Pharma Corp |
ZSAN |
10% Owner |
2015-01-30 |
1,363,636 |
|
0 |
Premium* |
|
Aeglea Biotherapeutics, Inc. |
AGLE |
10% Owner |
2016-04-12 |
0 |
2016-04-12 |
2,568,543 |
Premium* |
|
Zymeworks Inc |
ZYME |
10% Owner |
2019-01-31 |
2,898,647 |
2018-08-02 |
0 |
Premium* |
|
Elanco Animal Health Inc |
ELAN |
10% Owner |
2019-03-11 |
0 |
2019-03-11 |
0 |
Premium* |
|
Avidity Biosciences, Inc. |
RNA |
|
2020-06-16 |
2,169,396 |
2020-06-16 |
0 |
Premium* |
|
Sigilon Therapeutics, Inc. |
SGTX |
10% Owner |
2020-12-08 |
2,744,443 |
2020-12-08 |
0 |
Premium* |
|
Prevail Therapeutics Inc. |
PRVL |
10% Owner |
2021-01-22 |
100 |
2021-01-22 |
0 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2022-11-30 |
100 |
2022-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ICGN |
Icagen Inc |
10% Owner |
|
2005-02-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
175,000 |
|
- |
|
IONS |
Ionis Pharmaceuticals Inc |
10% Owner |
|
2005-08-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,500,000 |
|
- |
|
UTHR |
United Therapeutics Corp |
10% Owner |
|
2008-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,150,837 |
|
- |
|
ZSAN |
Zosano Pharma Corp |
10% Owner |
|
2015-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,363,636 |
|
- |
|
ICGN |
Icagen Inc |
10% Owner |
|
2005-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
125,340 |
300,340 |
|
- |
|
AGLE |
Aeglea Biotherapeutics, I... |
10% Owner |
|
2016-04-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,010,924 |
2,068,543 |
0 |
- |
|
ELAN |
Elanco Animal Health Inc |
10% Owner |
|
2019-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(293,290,000) |
0 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
|
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,169,396 |
2,169,396 |
0 |
- |
|
SGTX |
Sigilon Therapeutics, Inc... |
10% Owner |
|
2020-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,444,443 |
2,444,443 |
0 |
- |
|
AGLE |
Aeglea Biotherapeutics, I... |
10% Owner |
|
2016-04-12 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
2,568,543 |
1.5 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2022-11-30 |
4 |
B |
$12.50 |
$374,908,350 |
D/D |
29,992,668 |
100 |
2.45 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-02 |
4 |
S |
$13.31 |
$258,214 |
D/D |
(19,400) |
3,937,685 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-03 |
4 |
S |
$13.55 |
$22,358 |
D/D |
(1,650) |
3,936,035 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-11-06 |
4 |
S |
$14.00 |
$9,800,000 |
D/D |
(700,000) |
3,148,647 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-29 |
4 |
S |
$14.26 |
$32,969 |
D/D |
(2,312) |
3,924,294 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-31 |
4 |
S |
$14.26 |
$9,982 |
D/D |
(700) |
3,920,154 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-10 |
4 |
S |
$14.28 |
$27,103 |
D/D |
(1,898) |
3,934,137 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-14 |
4 |
S |
$14.28 |
$42,840 |
D/D |
(3,000) |
3,926,606 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-09-13 |
4 |
S |
$14.32 |
$299,288 |
D/D |
(20,900) |
3,873,418 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-13 |
4 |
S |
$14.33 |
$64,929 |
D/D |
(4,531) |
3,929,606 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-08-30 |
4 |
S |
$14.35 |
$49,364 |
D/D |
(3,440) |
3,920,854 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-09-10 |
4 |
S |
$14.44 |
$64,980 |
D/D |
(4,500) |
3,915,654 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-09-18 |
4 |
S |
$14.56 |
$100,027 |
D/D |
(6,870) |
3,850,674 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-09-14 |
4 |
S |
$14.58 |
$131,351 |
D/D |
(9,009) |
3,864,409 |
0 |
- |
|
ZYME |
Zymeworks Inc |
10% Owner |
|
2018-09-17 |
4 |
S |
$14.58 |
$100,092 |
D/D |
(6,865) |
3,857,544 |
0 |
- |
|
35 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|